Challa Group has entered into a strategic partnership with the World Smart Cities Forum (WSCF), USAUK, and iHolding (UK) to build a state-of-the-art cancer treatment facility in Andhra Pradesh.
A letter of intent (LOI) was signed by five collaborating companies at a ceremony in Vijayawada for the construction of the centre. This follows a previously signed memorandum of understanding (MoU) between Challa Group and WSCF. The proposed cancer centre will be constructed on 25 acres of land, with the exact location to be finalised after consultation with the state government.
Additionally, OMEXA Biologics has teamed up with WSCF to establish a cancer drug production facility on-site. As part of its ongoing initiatives, Challa Group also revealed plans to develop a multi-purpose industrial park in Donakonda.